Founded Year



Series A | Alive

Total Raised


Last Raised

$10M | 3 yrs ago

Mosaic Score

+100 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Myia Health

Myia provides a platform for optimizing virtual healthcare delivery through Remote Patient Monitoring, predictive analytics, process control, and workflow orchestration. The platform ingests a wide range of real-world data from curated sensors and sources, transforming it through applied machine intelligence into objective clinical insights. Harnessing the power of human data, Myia equips clinicians with the precise information they need to both optimize care and prevent unplanned events.

Myia Health Headquarter Location

353 Broadway

San Francisco, California, 94133,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Myia Health's Products & Differentiation

See Myia Health's products and how their products differentiate from alternatives and competitors

  • Myia

    Myia is an AI-driven driven operating system for scalable virtual care. Myia makes it easy for healthcare organizations to support the transformation to the home as a key venue of care.

Expert Collections containing Myia Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Myia Health is included in 6 Expert Collections, including Medical Devices.


Medical Devices

8,442 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

3,232 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Hospital

98 items

Startups recreating how healthcare is delivered


Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)



2,833 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.


Health IT

11,555 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

Myia Health Patents

Myia Health has filed 1 patent.

The 3 most popular patent topics include:

  • Cardiac arrhythmia
  • Cardiac electrophysiology
  • Electrodiagnosis
patents chart

Application Date

Grant Date


Related Topics



Cardiac arrhythmia, Electrophysiology, Electrodiagnosis, Cardiac electrophysiology, Electroencephalography


Application Date


Grant Date


Related Topics

Cardiac arrhythmia, Electrophysiology, Electrodiagnosis, Cardiac electrophysiology, Electroencephalography



Latest Myia Health News

Myia Health Names Former Blue Cross Blue Shield MN CEO Craig Samitt Executive Chairman

Jul 21, 2022

San Francisco, California, UNITED STATES SAN FRANCISCO, July 21, 2022 (GLOBE NEWSWIRE) -- Myia Health, a leading enterprise predictive analytics and virtual healthcare delivery platform, announced today the appointment of Dr. Craig Samitt, former President & CEO of Blue Cross and Blue Shield of Minnesota and Managing Director of ITO Advisors, as Executive Chairman. Samitt brings years of experience across the healthcare sector to Myia Health, spanning leadership roles at both health plans and health systems. "The healthcare system is in great need of transformation to make the home a key venue of care, and to do that, we have to equip health systems with the technology and information necessary to provide a personalized and preventative model of care,” said Samitt. “Myia has created an end-to-end platform that encompasses risk analytics, RPM, AI driven triage, telehealth, and care management, and it is powering the nation’s first and largest virtual hospital, Mercy Virtual. This technology, vision, and proven performance will act as an accelerant for our industry’s transformation toward value.” Dr. Samitt joins Myia Health after recently serving as President & CEO of Blue Cross and Blue Shield of Minnesota. Previously, he held healthcare leadership roles including Chief Clinical Officer and President of Anthem’s Diversified Business Group, President & CEO of HealthCare Partners, and President & CEO of Dean Health System. In his current capacity as Managing Director of ITO Advisors, he serves on numerous public, private, and non-profit boards. “Over the course of his career, Dr. Samitt has led transformational change at some of the nation’s leading health systems and health plans, and brings that extensive expertise and a strong passion to Myia Health,” said Simon MacGibbon, Co-Founder and CEO of Myia Health. “He has dedicated his career to the modernization, re-invention and improvement of the care delivery space, all of which is a perfect fit for Myia’s vision to improve the standard of care and eliminate avoidable costs in healthcare.” Samitt’s appointment comes during a year of momentum for Myia Health. The company introduced a new strategic advisory board , made up of renowned clinical, payer, and health system leaders and investors and also announced a new partnership with BioIntellisense . Myia powers the nation’s leading virtual hospital, Mercy Virtual, and is backed by clinical partners like the American College of Cardiology. About Myia Health Myia Health is the only comprehensive virtual care management platform that optimizes patient outcomes, clinical operations, and the economics of distributed healthcare delivery. Powered by advanced analytics and machine learning, the Myia platform seamlessly connects patient-reported and physiological data to clinical actions and outcomes, facilitating individualized care to patients in their homes. Founded in 2017, the Myia platform powers the world’s first and largest virtual hospital, Mercy Virtual; has helped transform the nation’s leading value-based systems; and partners with a new generation of health-at-home disruptors to help them deliver customer-centric, convenient, and affordable care. For more information, please visit . Myia Health

Nov 11, 2021
News 11/12/21

Myia Health Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Myia Health Rank

  • When was Myia Health founded?

    Myia Health was founded in 2017.

  • Where is Myia Health's headquarters?

    Myia Health's headquarters is located at 353 Broadway, San Francisco.

  • What is Myia Health's latest funding round?

    Myia Health's latest funding round is Series A.

  • How much did Myia Health raise?

    Myia Health raised a total of $16.75M.

  • Who are the investors of Myia Health?

    Investors of Myia Health include BootstrapLabs, Mercy Health, The Boston Consulting Group, Zetta Venture Partners, American College of Cardiology and 3 more.

  • Who are Myia Health's competitors?

    Competitors of Myia Health include Biofourmis and 6 more.

  • What products does Myia Health offer?

    Myia Health's products include Myia .

  • Who are Myia Health's customers?

    Customers of Myia Health include Mercy Virtual, Washington University School of Medicine, Baylor College of Medicine and 3 more.

You May Also Like

Babyscripts Logo

Babyscripts is a doctor-delivered, digital health tool for prenatal care, enhancing the doctor/patient relationship outside of the clinic's walls during routine, low-risk pregnancy care and providing remote monitoring to better identify high-risk pregnancies.

Sensome Logo

Sensome develops micro-sensor technology for smart medical devices. Sensome's sensing technology can be integrated with any medical device to reliably identify biological tissues in contact with the device. The technology combines micrometric impedance sensors that communicate wirelessly outside the body and machine learning algorithms for accurate and predictive real-time analysis.

TytoCare Logo

TytoCare connects people to clinicians to provide virtual home examinations and diagnosis solutions. TytoCare's solutions are designed to enable a comprehensive medical exam with clinicians, from any location.

Glooko Logo

Glooko's universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. Glooko's systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake.

EarlySense Logo

EarlySense provides contact-free, continuous monitoring solutions for the medical and consumer digital health markets. EarlySense's patented sensor and advanced algorithms monitor and analyze cardiac, respiratory, sleep and motion parameters. Used in hospitals and healthcare facilities worldwide, EarlySense assists clinicians in early detection of patient deterioration, helping to prevent adverse events, including code blues, preventable ICU transfers, patient falls and pressure ulcers. Additionally, the company's myEarlySense smart home-compatible consumer solution brings hospital-proven technology to the home, providing valuable data regarding wellness and sleep.

Element Science

Element Science focuses on solutions at the intersection of life-saving therapies, wearable devices, and patient-centric design. The company develops a cost-effective wearable therapeutic device that aims to re-define the treatment for temporary periods of elevated sudden cardiac death risk.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.